Vanguard Capital Management’s Century Therapeutics IPSC Stock Holding History
Bought
Maintained
Sold
Other funds holding IPSC
Vanguard Capital Management's IPSC Position: Q3 2026 in Review
Vanguard Capital Management reduced its Century Therapeutics (IPSC) stake by 0.19% in Q3 2026, selling an estimated $22.7K and leaving 5,692,587 shares worth $9.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2771.
Vanguard Capital Management first reported a position in IPSC in Q1 2026 and has held it in 3 quarters since. The position peaked at $14M in Q2 2026. 102 funds tracked by Wall St. Rank hold IPSC as of Q3 2026.
- Vanguard Capital Management held 5,692,587 shares of Century Therapeutics worth $9.7M as of Q3 2026.
- Vanguard Capital Management sold 11,093 Century Therapeutics shares in Q3 2026, an estimated $22.7K.
- Century Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2771 holding.
- Vanguard Capital Management first reported a position in Century Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Century Therapeutics position peaked at $14M in Q2 2026.
- 102 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.